The US Food and Drug Administration approves Wednesday, June 18, Gilead Sciences lenacapavir, a twice-yearly injection, for preventing HIV infection.
Full story: https://www.rappler.com/science/life-health/united-states-fda-approve-injection-hiv-prevention/
